Vaccine sharing behaviour in the COVID-19 pandemic: the impact of narratives and peer effects

How to cite

Finster, Simon; Amador, Michelle González; Lock, Edwin. 2021. "Vaccine sharing behaviour in the COVID-19 pandemic: the impact of narratives and peer effects." AEA RCT Registry. AEARCTR-0008422. https://doi.org/10.1257/rct.8422-1.1

Download: BibTeX · RIS — for reference managers without a browser translator. Zotero and most others pick up this page's citation metadata directly.

Simon Finster* , Michelle González Amador , Edwin Lock

* Primary investigator

Registry ID
AEARCTR-0008422
DOI
https://doi.org/10.1257/rct.8422-1.1
First registered
Last updated
Status
Completed
Trial dates
2021-12-01 – 2022-05-31
Countries
United Kingdom of Great Britain and Northern Ireland ()
JEL codes
C21, C90, C92, D64, D91, I00, I12.
Registry record
http://www.socialscienceregistry.org/trials/8422

Abstract

We conduct a virtual lab experiment to understand individuals' vaccine sharing attitudes and behaviour in the context of altruistic and self-interested narratives, with and without peer effects. A 2-by-3 factorial design is used to determine the isolated impact as well as the interaction of these treatments on vaccine sharing with resource-poor countries, which is approximated by monetary donations from subject payments to the vaccine access initiative COVAX. The main interventions are complemented by detailed socio-economic surveys, including attitudes towards vaccines and vaccine history.

Intervention

We introduce a 3x2 factorial design, where subjects are randomly assigned to one of six experimental conditions. In the first dimension, we present our subjects with facts appealing to either altruism or self-interest (plus control group) as a narrative for sharing vaccines. These facts are presented by means of a short video. Subjects then have the opportunity to share any amount of their earnings from the experiment as a donation to the vaccine access initiative COVAX. In the second dimension, we observe peer effects: after learning the average sharing behaviour of their peer group, subjects can revise their pledge. For all subjects, we also collect relevant covariates such as data on vaccine history, exposure to hardship during the pandemic, risk attitudes, inequity aversion, baseline level of altruism, and standard demographics.

Experimental design

All treatments + control are introduced to the survey and consent is confirmed. Treatments A, S, PA, and PS (see full pre-analysis plan for reference to treatment names) view informational video with altruism or self-interest narrative. All treatments + control group learn their earnings (8 GBP) and can make a pledge towards COVAX. Treatments P, PA, PS are informed that they are participating in a group (defined by 'within session' and 'within treatment'), and will see the group’s total and average-per-person donation subsequent to their pledge, while their own donation choice will remain confidential. Subjects are not informed that there will be an opportunity to revise the pledge. Treatments P, PA, PS are shown their group’s total and average-per-person donation. All treatments + control can revise their pledge. All treatments + control are asked to complete an unpaid survey.

Design details

Randomization method
Randomization done by OTree Software, by a computer.
Randomization unit
Randomized unit: individual.
Clusters
0
Observations
1500
Arms
250 subjects per treatment arm.
Primary outcomes
Dependent Variable 1: Amount of money (in GBP) that subjects pledge towards COVAX, from their earnings on the experiment (initial and final pledge).
Secondary outcomes
Dependent variable 2: Indicator that takes on the value 1 if subjects revise their donation, and zero otherwise.

Cited by

No citation data available for this registration yet.

Keywords